I. Angelidis (Chalandri, Greece), F. Gamarra (Straubing, Germany)
Changes in Structure and Stiffness of the Lung Extracellular Matrix in Lung Cancer
M. Narciso (Barcelona, Spain), N. Díaz-Valdivia (Barcelona, Spain), C. Junior (Barcelona, Spain), J. Otero (Barcelona, Spain), J. Alcaraz (Barcelona, Spain), D. Navajas (Barcelona, Spain), R. Farre (Barcelona, Spain), I. Almendros (Barcelona, Spain), N. Gavara (Barcelona, Spain)
|   |
Endobronquial ultrasound transbronchial needle aspiration (EBUS-TBNA) performance for the determination of Programmed Death Ligand-1 (PDL-1) expression in non-small cell lung cancer (NSCLC)
M. Zuil Moreno (Lleida, Spain), D. Polanco (Lleida, Spain), E. Gracia-Lavedan (Lleida, Spain), L. Pinilla (Lleida, Spain), S. Gatius (Lleida, Spain), F. Barbé (Lleida, Spain)
| |
Extracellular vesicles (EVs) as diagnostic tools in the phenotypic determination of lung tumors
M. Cambier (Liège, Belgium), F. Muller (Liège, Belgium), M. Henket (Liège, Belgium), C. Remacle (Liège, Belgium), J. Guiot (Liège, Belgium), I. Struman (Liège, Belgium)
| |
Non small cell lung cancer patients with EGFR mutation : therapeutic sequences in a real life setting
G. BERARDI (Grenoble, France), N. Girard (Paris, France), F. De Fraipont (Grenoble, France), C. Decroisette (Annecy, France), S. Gazzerie (Grenoble, France), D. Moro Sibilot (Grenoble, France), A. Toffart (Grenoble, France)
| |
Detection of lung cancer using a single blood biomarker and tobacco history in a high risk cohort
M. Borg (Aalborg, Denmark), L. Nederby (Vejle, Denmark), S. Wen (Vejle, Denmark), T. Hansen (Vejle, Denmark), A. Jakobsen (Vejle, Denmark), R. Andersen (Vejle, Denmark), U. Weinreich (Aalborg, Denmark), O. Hilberg (Vejle, Denmark)
| |
Involvement of TLRs and WNT pathway in lung cancer in COPD patients
A. Iglesias Coma (Madrid, Spain), N. Ceron (Palma, Spain), E. Martínez (Palma, Spain), A. Martin (Palma, Spain), A. Obrador (Palma, Spain), J. Sauleda (Palma, Spain)
| |
Terminal effector Tregs in metastatic lymph nodes of lung cancer patients
I. Kwiecien (Warszawa, Poland), E. Rutkowska (Warszawa, Poland), A. Raniszewska (Warszawa, Poland), J. Bednarek (Warszawa, Poland), R. Sokolowski (Warszawa, Poland), P. Rzepecki (Warszawa, Poland), J. Domagala-Kulawik (Warszawa, Poland)
| |
Current Practice in Molecular Genetic Testing in NSCLC Patients in Czechia. Data from the TULUNG Registry 2011-2021.
M. Bratová (Brno, Czech Republic), K. Brat (Brno, Czech Republic), J. Skrickova (Brno, Czech Republic), K. Hurdalkova (Brno, Czech Republic), M. Pesek (Pilsen, Czech Republic), M. Svaton (Pilsen, Czech Republic), L. Havel (Prague, Czech Republic), L. Koubkova (Prague, Czech Republic), M. Hrnciarik (Hradec Kralove, Czech Republic), O. Fischer (Olomouc, Czech Republic), J. Krejci (Praque, Czech Republic)
| |
ADAMTS1 as a potential tumor suppressor in lung adenocarcinoma
C. Chang (Kaohsiung, Taiwan), H. Lee (Kaohsiung, Taiwan), K. Wu (Kaohsiung, Taiwan), Y. Hsu (Kaohsiung, Taiwan)
| |
Cancer associated fibroblasts subtypes are associated with histological features, immune environment and prognosis in resected non small cell lung cancer
E. Guenzi (paris, France), K. El Husseini (paris, France), A. Guyard (paris, France), A. Mailleux (paris, France), P. Mordant (paris, France), A. Couvelard (paris, France), B. Crestani (paris, France), A. Cazes (paris, France), G. Zalcman (paris, France), n. poté (paris, France)
| |
Analysing the molecular landscape of squamous cell carcinoma through simultaneous targeted DNA and RNA-based next-generation sequencing
J. Moes-Sosnowska (Warsaw, Poland), M. Skupinska (Kazun Nowy, Poland), U. Lechowicz (Warsaw, Poland), P. Skronska (Warsaw, Poland), E. Szczepulska-Wojcik (Warsaw, Poland), A. Stepniewska (Warsaw, Poland), A. Rozy (Warsaw, Poland), R. Langfort (Warsaw, Poland), P. Rudzinski (Warsaw, Poland), T. Orlowski (Warsaw, Poland), D. Popiel (Kazun Nowy, Poland), M. Wieczorek (Kazun Nowy, Poland), J. Chorostowska-Wynimko (Warsaw, Poland)
| |
Effects of the tumor microenvironment and molecular forms of alpha1-antitrypsin on NSCLC viability
A. Gründing (Hannover, Germany), T. Welte (Hannover, Germany), S. Janciauskiene (Hannover, Germany)
| |
The Role of Interleukin 6 and Cyclooxygenase 2 In Progressivity and Metastatic Process in Andavce Non Small Cell Lung Cancer
A. Santoso (Makassar, Indonesia), R. Rasiha (Makassar, Indonesia), S. Munawwarah (Makassar, Indonesia), A. Mustang (Makassar, Indonesia)
| |